ISPOR Latin America 2019 - Session Details

Plenaries

WELCOME AND FIRST PLENARY SESSION

8:30 AM–10:30 AM 13 Sep, 2019

Room TU-VW (5th fl/Piso 5)

Who's Attending (130)

Dario Balan, BEcon, MSc (c)

Fellow ResearcherInstitute for Clinical Effectiveness and Health Policy (IECS)

Ana Pérez-Galán, MD MSc

HTA/RAMinistry of Health

Juan Carlos Alandete Manotas, MD

Regional Market Access DirectorBayer LATAM

Ramon Camacho, MS, PhD, MBA

Regional Director, Latin America Market AccessMerck Sharp Dohme

Dalila Garcia Rojas, MSc in Epidemiology

Healthcare Risk AnalystEPS y Medicina Prepagada Suramericana S.A.

Maria Camila Bustos Márquez, MD MPH

Access ManagerAMGEN

Jorge Elgart, BEc, MSc

ResearcherCENEXA. Centro de Endocrinología Experimental y Aplicada (UNLP-CONICET)

Claudia S Soares, MD, MPH, PhD

Sr Director Value Access & RWE GlaxoSmithKline

Hermán Soto Molina, MSc

Health Economics Senior ConsultantHS Estudios Farmacoeconómicos S.A. de C.V.

Dra. Lucila Rey-Ares, MSc

Asesora, Unidad de Coordinación General, Secretaría de Gobierno de Salud de la Nación y Subgerente de Auditoría MédicaCentro de Educación Médica e Investigación Clínica “Norberto Quirno”

João Carvalho, BSc, MBA

Business Development ManagerRoche Diagnostics Brazil

Ulises Garay, Msc

Market Access ManagerRoche Diagnostics

See all

Moderator (1)

Manuel A. Espinoza, MD, MSc, PhD

Professor, Department of Public Health & ChiefCatholic University of Chile

Speaker (10)

Rafael Alfonso-Cristancho, MD, PhD, MSc

Senior Director Value Evidence and OutcomesGlaxoSmithKline plc.

Federico Augustovski, MD, MSc, PhD

DirectorInstitute for Clinical Effectiveness and Health Policy (IECS)

Yajaira Bastardo, PhD

Profesora de Farmacoeconomía y Administración Farmacéutica, Facultad de FarmaciaUniversidad Central de Venezuela

See all

Sub-Sessions

Plenaries

1. WELCOME FROM ISPOR CEO/EXECUTIVE DIRECTOR

8:30 AM–10:30 AM 13 Sep, 2019

Room TU-VW (5th fl/Piso 5)

Plenaries

2. WELCOME FROM ISPOR PAST-PRESIDENT

8:30 AM–10:30 AM 13 Sep, 2019

Room TU-VW (5th fl/Piso 5)

Plenaries

3. CONFERENCE PROGRAM OVERVIEW FROM PROGRAM COMMITTEE CO-CHAIRS

8:30 AM–10:30 AM 13 Sep, 2019

Room TU-VW (5th fl/Piso 5)

Plenaries

4. FIRST PLENARY SESSION: THE ROLE OF DATA SUPPORTING AN EFFECTIVE DECISION-MAKING PROCESS

8:30 AM–10:30 AM 13 Sep, 2019

Room TU-VW (5th fl/Piso 5)